Montreal, Canada

Yannick Rose

This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignee: Universitéde Montreal. Active years: 2024-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yannick Rose. Retrieved from https://idiyas.com/inventor/yannick-rose-xhfnt72h

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 9.3

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2024-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Inventor Yannick Rose

Introduction

Yannick Rose is a notable inventor based in Montréal, Canada. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds for treating proliferative diseases. With a total of 2 patents to his name, his work is recognized for its potential impact on healthcare.

Latest Patents

Yannick Rose's latest patents include innovative Pyrido[3,2-d]pyrimidine compounds. These compounds are designed for use in treating proliferative diseases or conditions associated with RAF and RAS gene mutations. The patents detail the compounds, compositions, and their applications, emphasizing their pharmaceutical relevance.

Career Highlights

Yannick Rose is affiliated with the Université de Montréal, where he conducts research and development in his field. His work has garnered attention for its potential to address significant health challenges through innovative chemical solutions.

Collaborations

Yannick collaborates with esteemed colleagues, including Pierre Louis Beaulieu and Eric Beaulieu. Their combined expertise enhances the research and development efforts within their projects.

Conclusion

Yannick Rose's contributions to medicinal chemistry through his patents and collaborations highlight his role as an influential inventor in the field. His work continues to pave the way for advancements in the treatment of proliferative diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…